Singular Genomics Systems, Inc.
DelistedCIK 1850906fmd_1AT7GYMQNCDFJKA0JS3FBCZF01Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2024, 19 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Total revenues | – | 0 | 1 | 3 |
| Cost of revenue | – | 0 | 1 | 3 |
| Gross profit | – | 0 | (0) | (1) |
| Research and development | 21 | 33 | 46 | 48 |
| Selling, general and administrative | 6 | 29 | 47 | 54 |
| Total operating expenses | 28 | 61 | 93 | 102 |
| Operating income | (28) | (61) | (93) | (103) |
| Interest expense | 1 | 1 | 1 | 1 |
| Interest and investment income | 0 | 1 | 3 | 9 |
| Other non-operating income (expense) | 0 | (37) | 3 | 8 |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income | (28) | (99) | (91) | (95) |